Arrowstreet Capital, Limited Partnership Dr Reddys Laboratories LTD Put Options Transaction History
Arrowstreet Capital, Limited Partnership
- $114 Billion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RDY
# of Institutions
237Shares Held
23.8MCall Options Held
14.6KPut Options Held
2.8K-
Robeco Institutional Asset Management B.V.2.07MShares$30.1 Million0.33% of portfolio
-
Royal Bank Of Canada Toronto, A62.06MShares$29.9 Million0.04% of portfolio
-
Morgan Stanley New York, NY2.03MShares$29.6 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.95MShares$28.4 Million0.25% of portfolio
-
Black Rock Inc. New York, NY1.8MShares$26.2 Million0.0% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.42B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...